Keytruda is a prescription drug that’s given as an intravenous (IV) infusion (and injection into a vein over a period of time). Learn about how the drug is given, how often you’ll receive doses, and ...

Imfinzi (durvalumab) and Keytruda (pembrolizumab) are prescription drugs used to treat various forms of cancer. Both drugs are administered as intravenous (IV) infusion into a vein. Your dosage for ...

Opdivo (nivolumab) and Keytruda (pembrolizumab) are brand-name biologic drugs prescribed for several types of cancer. They are given by a healthcare professional as an intravenous (IV) infusion. This ...

Findings from a phase 2 trial showed improvements in relapse-free survival with an mRNA vaccine plus Keytruda compared with Keytruda alone in patients with high-risk resected melanoma. The combination ...

Keytruda is a monoclonal antibody that was specifically designed in the lab to target cancer cells. (Picture: Pexels) Keytruda boosts immune response to fight various cancers It blocks PD-1 pathway, ...

Keytruda is approved for early-stage non-small cell lung cancer post-surgery and chemotherapy, improving disease control and survival by 27%. The drug works by enhancing immune system recognition of ...

Keytruda can cause mild side effects, including fatigue, skin rash, diarrhea, and joint or muscle pain. These are usually manageable and may lessen over time. Serious side effects of Keytruda include ...